Can Proteomics Help in Understanding Drug Resistance?
Drug resistance is a significant hurdle in effective cancer treatment. Proteomic studies can reveal the mechanisms behind this resistance, such as the upregulation of drug efflux pumps or alterations in cell signaling pathways. By understanding these mechanisms, researchers can develop strategies to overcome resistance, such as combination therapies that target multiple pathways simultaneously.
